Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners

European Respiratory Journal

Volumn 26, Issue 2, 2005, Pages 298-304

  Drobniewski, Francis A ^a   Balabanova, Y M ^a,c   Ruddy, M C ^a   Graham, C ^b   Kuznetzov, S I ^d   Gusarova, G I ^d   Zakharova, S M ^e   Melentyev, A S ^c   Fedorin, I M ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Queen's Medical Research Institute   (United Kingdom)

^c Samara TB Service   (Russian Federation)

^d Samara Oblast Health Department   (Russian Federation)

^e Samara City TB Service   (Russian Federation)

Author keywords

HIV; Intravenous drug users; Prisons; Russia; Tuberculosis

Indexed keywords

AMPHETAMINE; BCG VACCINE; CANNABIS; COCAINE; OPIATE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRISONER; RISK ASSESSMENT; RISK REDUCTION; RUSSIAN FEDERATION; SOCIOECONOMICS; TREATMENT FAILURE; VIRUS INFECTION;

ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV SEROPREVALENCE; HUMANS; MALE; PATIENT COMPLIANCE; PREVALENCE; PRISONERS; RISK FACTORS; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS;

EID: 23144444469     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00136004     Document Type: Article

References (35)

1. UNAIDS report for 2003: most deaths and new infections ever; some good news. AIDS Treat News 2003; 396: 3.
2. Pokrovsky VV, Ladnaia NN, Buratsova EB, Sokolova EV. HTV infection surveillance in Russia in 2001. Moscow, Russian Federal AIDS Centre Update, 2002.
3. Drobniewski FA, Balabanova YM. The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium. Int J Infect Dis 2002; 6: Suppl. 1, S21-S31.
4. Shilova MV, Dye C. The resurgence of tuberculosis in Russia. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1069-1075.
5. Erokhin VV, Demikhova OV, Punga VV, Putova EV. New organisational forms of antituberculosis care under present conditions. Results and experience exchange of work in pilot regions. Scientific-and-Practical Conference (Moscow, September 25-27, 2002). Probl Tuberk 2003; 2: 48-50.
6. Drobniewski FA. Multiple-drug-resistant tuberculosis. Lancet 2000; 356: Suppl., s62.
7. Drobniewski FA, Pozniak AL. Molecular diagnosis, detection of drug resistance and epidemiology of tuberculosis. Br J Hosp Med 1996; 56: 204-208.
8. Narvskaia OV, Vishnevskii BI, El'kin AV, et al. Molecular genetic characteristics of Mycobacterium tuberculosis isolated from patients operated on for pulmonary tuberculosis. Probl Tuberk 2002; 3: 50-53.
9. Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis 2002; 6: 406-414.
10. Spradling P, Nemtsova E, Aptekar T, et al. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 2002; 6: 757-762.
11. Kruuner A, Hoffner SE, Sillastu. H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 3339-3345.
12. : the colliding epidemics of tuberculosis and HIV in Russia. Int J STD AIDS 2004; 15: 641-646.
13. Stern V. Problems in prisons worldwide, with a particular focus on Russia. Ann N Y Acad Sci 2001; 953: 113-119.
14. Coyle A, Stern V. Prison health and public health: the integration of prison health services. Report from a conference. London, Dept of Health and International Centre for Prison Studies, 2004.
15. Stern V. "Tuberculosis among prisoners". Report from the Second Interdisciplinary Expert Meeting on Prevention and Control in the Baltic Sea Region. Task Force for the control of communicable diseases in the Baltic Sea states. St. Petersburg, Council of the Baltic Sea states, 2002.
16. Samara AIDS Center Epidemiological Update. Samara, Samara Ministry of Health, 2004.
17. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russian. AIDS 2002; 16: F25-F31.
18. Coker R, Dimitrova B, Drobniewski F, et al. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis 2003; 7: 920-932.
19. Samara TB Service Annual Report. Samara, Samara Ministry of Health, 2002.
20. Copas AJ, Wellings K, Erens B, et al. The accuracy of reported sensitive sexual behaviour in Britain: exploring the extent of change 1990-2000. Sex Transm Infect 2002; 78: 26-30.
21. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001; 358: 1835-1842.
22. Power R, Nozhkina N. The value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS 2002; 16: 303-304.
23. Drobniewski F, Balabanova Y, Ruddy M, et al. Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. Emerg Infect Dis 2002; 8: 1320-1326.
24. Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005; 60: 130-135.
25. Drobniewski F, Tayler E, Ignatenko N, et al. Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment. Tuber Lung Dis 1996; 77: 199-206.
26. Coker R. Control of tuberculosis in Russia. Lancet 2001; 358: 434-435.
27. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1994; 49: 1193-1200.
28. New UK guidance on the prevention and control of transmission of HIV related and drug resistant tuberculosis. Commun Dis Rep CDR Wkly 1999; 9: 49.
29. Hurtig AK, Porter JD, Ogden JA. Tuberculosis control and directly observed therapy from the public health/human rights perspective. Int J Tuberc Lung Dis 1999; 3: 553-560.
30. Davies PD. Comparison of international guidelines on the control and prevention of tuberculosis. Monaldi Arch Chest Dis 2001; 56: 74-78.
31. White VL, Paliwalla M, Steves CJ, Jadhav D, Moore-Gillon J. Management of tuberculosis in a British inner-city population. J Public Health Med 2002; 24: 49-52.
32. Coker Rj, Dimitrova B, Drobniewski F, et al. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis 2003; 7: 920-932.
33. Coker R. Detention and mandatory treatment for tuberculosis patients in Russia. Lancet 2001; 358: 349-350.
34. Prikaz 109 Russian Ministry of Health. Prikaz on Improving of Tuberculosis Control Activities in the Russian Federation. Moscow, Ministry of Health, 2003.
35. Marco A, Cayla JA, Serra M, et al. Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 1998; 12: 967-971.